Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology
Patent
1996-11-26
1999-09-14
Elliott, George C.
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Method of regulating cell metabolism or physiology
514 44, 536 245, C12N 522, A61K 3170, C07H 2100
Patent
active
059522291
ABSTRACT:
Oligonucleotides are provided which are targeted to nucleic acids encoding human raf and capable of inhibiting raf expression. In preferred embodiments, the oligonucleotides are targeted to mRNA encoding human c-raf or human A-raf. The oligonucleotides may have chemical modifications at one or more positions and may be chimeric oligonucleotides. Methods of inhibiting the expression of human raf using oligonucleotides of the invention are also provided. The present invention further comprises methods of inhibiting hyperproliferation of cells and methods of treating abnormal proliferative conditions which employ oligonucleotides of the invention.
REFERENCES:
patent: 4806463 (1989-02-01), Goodchild et al.
patent: 4871838 (1989-10-01), Bos et al.
patent: 5004810 (1991-04-01), Draper et al.
patent: 5034506 (1991-07-01), Summerton et al.
patent: 5087617 (1992-02-01), Smith
patent: 5098890 (1992-03-01), Gewirtz et al.
patent: 5135917 (1992-08-01), Burch
patent: 5166195 (1992-11-01), Ecker et al.
patent: 5194428 (1993-03-01), Agrawal et al.
patent: 5264423 (1993-11-01), Cohen et al.
patent: 5276019 (1994-01-01), Cohen et al.
patent: 5286717 (1994-02-01), Cohen et al.
patent: 5563255 (1996-10-01), Monia et al.
patent: 5585479 (1996-12-01), Hoke et al.
patent: 5654284 (1997-08-01), Cook et al.
patent: 5656612 (1997-08-01), Monia
Gewirtz et al. Facilitating oligonucleotide delivery: Helping Antisense deliver on its promise. Proc. Natl. Acad. Sci. USA 93: 3161-3163, Apr. 1996.
Inoue et al. Sequnce-dependent hydrolysis of RNA using modified oligonucleotide splints and RNAse H. FEBS Letts. 215(2): 327-330, May 1987.
Milligan et al. Current concepts in antisense drug design. J. Med. Chem. 36(14): 1923-1937, Jul. 1993.
Milner et al. Selecting effective antisense reagents on combinatorial oligonucleotide arrays. Nature Biotechnol. 15: 537-541, Jun. 1997.
Monia et al. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nature Medicine 2(6): 668-675, Jun. 1996.
Anfossi et al., "An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines", Proc. Natl. Acad. Sci. 1989, 86, 3379-3383.
App et al., "Epidermal Growth Factor (EGF) Stimulates Association and Kinase Activity of Raf-1 with the EGF Receptor", Mol. Cell Biol. 1991, 11, 913-919.
Holt et al., "An Oligomer Complementary to c-myc mRNA Inhibits Proliferatin of HL-60 Promyelocytic Cells and Induces Differentiation", Mol. Cell Biol. 1988, 8, 963-973.
Kingston, R.E., in Current Protocols in Molecular Biology, John Wiley and Sons, NY, 1996.
P.E. Nielsen et al., "Sequence-Selective Recognition of DNA by Strand Displacement with a Thymine-Substituted Polyamide", Science 1991, 254, 1497.
Rapp et al., "The raf oncogenes", The Oncogene Handbook, E.P. Reddy, A.M. Skalka and T. Curran, eds., Elsevier Science Publishers, New York, 1988, pp. 213-253.
Riedel et al., "The Mitogenic response of T cells to interleukin-2 requires Raf-1", Eur. J. Immunol. 1993, 23, 3146-3150.
Sambrook et al., "Labeling the 5' Terminus of DNA with Bacteriophage T4 Polynucleotide Kinase", Molecular Cloning. A Laboratory Manual, Cold Spring Harbor Laboratory Press, 1989, vol. 2, p. 10.59.
Sambrook et al., "Labeling of Synthetic Oligonucleotides by Phosphorylation with Bacteriophage T4 Polynucleotide Kinase", Molecular Cloning. A Laboratory Manual, Cold Spring Harbor Laboratory Press, 1989, vol. 2, p. 11.31-.
Stanton and Cooper, "Activation of Human raf Transforming Genes by Deletion of Normal Amino-Terminal Coding Sequences", Mol. Cell. Biol. 1987, 7, 1171-1179.
Tornkvist et al., "Inhibition of Raf-1 Kinase Expression Abolishes Insulin Stimulation of DNA Synthesis in H4IIE Hepatoma Cells", J. Biol. Chem. 1994, 269, 13919-13921.
Wickstrom et al., "Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA", Proc. Nat. Acad. Sci. 1988, 85, 1028-1032.
Maister, P., "Isis' Antisense Drug Shows Promise for Retinitis", BioWorld Today, Apr. 29, 1994, p. 3.
Boggs Russell T.
Monia Brett P.
Elliott George C.
ISIS Pharmaceuticals Inc.
Larson Thomas G.
LandOfFree
Antisense oligonucleotide modulation of raf gene expression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense oligonucleotide modulation of raf gene expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotide modulation of raf gene expression will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1509420